• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾病综合征期间的脂质代谢紊乱:生理病理学与治疗]

[Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].

作者信息

Moulin B, Ollier J, Olmer M

机构信息

Service de Néphrologie, Hôpital de la Conception, CHU Marseille.

出版信息

Nephrologie. 1992;13(5):193-9.

PMID:1470293
Abstract

Both increased synthesis and decreased catabolism of lipoproteins may account for the severe hyperlipidemia which frequently occurs in patients with the nephrotic syndrome (NS). Nevertheless the complex relation between hyperlipidemia and proteinuria remains unclear and still debated. Increased levels of serum total cholesterol, of low-density lipoprotein and of apolipoprotein B are the most characteristic reported abnormalities placing these patients at high risks for atherosclerotic vascular disease. Moreover recent experiments have suggested that hyperlipidemia may also play a role in the progression of renal disease. Thus the reasons for using hypolipemic treatment are now growing in number and recent trials with lipid lowering medication have been successful without major side effects.

摘要

脂蛋白合成增加和分解代谢减少都可能是肾病综合征(NS)患者经常出现严重高脂血症的原因。然而,高脂血症与蛋白尿之间的复杂关系仍不清楚,仍存在争议。血清总胆固醇、低密度脂蛋白和载脂蛋白B水平升高是最具特征性的报告异常,使这些患者处于动脉粥样硬化性血管疾病的高风险中。此外,最近的实验表明,高脂血症也可能在肾脏疾病的进展中起作用。因此,使用降血脂治疗的理由现在越来越多,最近使用降脂药物的试验取得了成功,且没有重大副作用。

相似文献

1
[Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].[肾病综合征期间的脂质代谢紊乱:生理病理学与治疗]
Nephrologie. 1992;13(5):193-9.
2
Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?肾病综合征中高脂血症的积极管理是必要的吗?
Kidney Int Suppl. 1992 Oct;38:S134-41.
3
Rationale and management of hyperlipidemia of the nephrotic syndrome.肾病综合征高脂血症的原理及管理
Am J Med. 1989 Nov;87(5N):3N-11N.
4
The hyperlipidemia of the nephrotic syndrome.肾病综合征的高脂血症
Am J Med. 1989 Nov;87(5N):45N-50N.
5
Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.肾病综合征/蛋白尿患者脂质异常的发病机制:临床意义
Miner Electrolyte Metab. 1993;19(3):115-26.
6
The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
Turk J Pediatr. 2002 Jan-Mar;44(1):40-4.
7
Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.肾病性高脂血症:脂蛋白分解代谢和合成均存在原发性异常。
Miner Electrolyte Metab. 1992;18(2-5):212-6.
8
Proteinuria, hyperlipidemia, and the kidney.蛋白尿、高脂血症与肾脏。
Miner Electrolyte Metab. 1993;19(3):127-36.
9
Should hyperlipidemia in children with the nephrotic syndrome be treated?患有肾病综合征的儿童的高脂血症是否应该治疗?
Pediatr Nephrol. 1999 Jan;13(1):77-84. doi: 10.1007/s004670050568.
10
Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.肾病综合征中的脂质异常:他汀类药物的治疗作用
J Nephrol. 2001 Nov-Dec;14 Suppl 4:S70-5.